|
|
|
| home > white papers > Crossing the Blood Brain Barrier (BBB): Which Route to Take? - Aptar Pharma |
|
|
 WHITE PAPERS |
|
Aptar Pharma
|
|
Crossing the Blood Brain Barrier (BBB): Which Route to Take?
|
|
Aptar Pharma recently hosted an expert panel/roundtable on the various
approaches to treating central nervous system (CNS) diseases. This
international scientific forum was held in Paris, France on December
5th, 2014. The roundtable was organized to explore and exchange views on
the challenges, approaches and opportunities that exist with regard to
effectively crossing the blood brain barrier (BBB) and successfully
treating a host of CNS diseases.
|
|
|
|
|
|
|
|
 |
News and Press Releases |
 |
Teknova completes FDA notification for room temperature-stable viral transport medium
Hollister, CA – 16 Dec 2020. Teknova, a leading manufacturer of
cell culture media and supplements, purification buffers, and molecular
biology reagents, has completed the process of FDA notification for its
Active Viral Transport Medium (ATM). ATM is a room temperature-stable
version of Teknova’s CDC formulation Viral Transport Medium (VTM) and is
manufactured under GMP conditions in compliance with ISO 13485
standards.
More info >> |
|
 |
White Papers |
 |
|
Case Study: Cmed’s Mobile Data Management Solution
Cmed Clinical Services
The trial presented to Cmed was a randomized, double blinded, placebo
and active controlled study to evaluate the cardiac safety of multiple
doses of [study drug] in health volunteers.
The pharmaceutical
company, who were into the second year of development of a potential
blockbuster compound for the treatment of chronic myelogenous leukaemia
(CML), were requested by the FDA to design a trial to provide
information on the cardiac safety of different dose levels of the study
drug in healthy adult volunteers. The primary objective of the study was
specifically to find the maximum tolerated dose before QTc levels
became unsafe. All development of the compound was put on hold until the
results of this study were submitted to the FDA and approval granted
for the compound to progress into full development.
More info >> |
|
 |
Industry Events |
 |
12th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology
8-11 February 2021, Vienna, Austria
In continuation of the very successful scientific meetings in Budapest, Paris, Berlin, Florence, Geneva, Barcelona, Malta, Istanbul, Lisbon, Glasgow and Granada, the 12th PBP World will be held in Vienna from 8-11 Feb 2021. This every two year held conference has gained an ever increasing impact among the pharmaceutical scientists: With up to 1000 submitted abstracts and about 1300 participants it has become a well-established major meeting, attracting scientists from all over the world.
More info >> |
|
|
|
